Tirtha Chakraborty, Ph.D.

Tirtha Chakraborty, Ph.D.

Chief Scientific Officer and Head of Technical OperationsatVor Biopharma· In proxies 2022–2024

Pay in FY2023-31% from the year before · Vor Biopharma stock -66.2% the same year

Tirtha Chakraborty, Ph.D. was paid $1.3M in FY2023 (Dec), down 31%. Vor Biopharma stock fell 66.2% that year.

Pay$100 in the stock at the end of FY21 → $19
Pay is from the Summary Compensation Table of each Vor Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vor BiopharmaPublic company · 4 yr
    • Chief Scientific Officer and Head of Technical Operations2022 – Present · 4 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?